Alexandria Capital’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,671
| Closed | -$430K | – | 261 |
|
|
2021
Q2 | $430K | Sell |
1,671
-3,810
| -70% | -$980K | 0.04% | 196 |
|
|
2021
Q1 | $1.64M | Sell |
5,481
-123
| -2% | -$36.9K | 0.17% | 129 |
|
|
2020
Q4 | $1.43M | Sell |
5,604
-982
| -15% | -$250K | 0.15% | 128 |
|
|
2020
Q3 | $1.64M | Sell |
6,586
-17
| -0.3% | -$4.23K | 0.2% | 123 |
|
|
2020
Q2 | $2.29M | Buy |
6,603
+28
| +0.4% | +$9.73K | 0.3% | 99 |
|
|
2020
Q1 | $1.76M | Sell |
6,575
-9
| -0.1% | -$2.41K | 0.29% | 95 |
|
|
2019
Q4 | $2.13M | Sell |
6,584
-89
| -1% | -$28.8K | 0.29% | 98 |
|
|
2019
Q3 | $1.82M | Sell |
6,673
-33
| -0.5% | -$9.02K | 0.27% | 101 |
|
|
2019
Q2 | $3.58M | Buy |
6,706
+4
| +0.1% | +$2.14K | 0.51% | 64 |
|
|
2019
Q1 | $3.38M | Buy |
6,702
+7
| +0.1% | +$3.53K | 0.49% | 68 |
|
|
2018
Q4 | $3.3M | Sell |
6,695
-18
| -0.3% | -$8.88K | 0.54% | 57 |
|
|
2018
Q3 | $6.14M | Buy |
6,713
+49
| +0.7% | +$44.8K | 0.9% | 31 |
|
|
2018
Q2 | $4.88M | Buy |
6,664
+8
| +0.1% | +$5.86K | 0.73% | 37 |
|
|
2018
Q1 | $10.6M | Buy |
6,656
+23
| +0.3% | +$36.7K | 1.57% | 12 |
|
|
2017
Q4 | $5.94M | Buy |
+6,633
| New | +$5.94M | 0.87% | 31 |
|